Zofenopril calcium

This classification denotes an ace inhibitor with the molecular formula 2C22H22NO4S2.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 88ZQ329PU2, chemically known as l-proline, 1-(3-(benzoylthio)-2-methyl-1-oxopropyl)-4-(phenylthio)-, calcium salt, (1(r*),2alpha,4alpha)- but more generally known as zofenopril calcium, which bears US NIH Compound Identifier 3033690. European Medicines Agency schedules Zofenopril calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05191MIG. Most nations, for tariff and trade purposes, schedule zofenopril calcium under HS 29339990 and SITC 51577. As of Q4 2014, ZOFENOPRIL CALCIUM remains US FDA's Preferred Term for this commodity. Zofenopril calcium bears US NLM identifiers UMLS ID C0873162 and NCI Concept Code C82220. SMILES: C[C@H](CSC(=O)C1CCCCC1)C(=O)N2C[C@H](C[C@H]2C(=O)[O-])SC3CCCCC3.C[C@H](CSC(=O)C1CCCCC1)C(=O)N2C[C@H](C[C@H]2C(=O)[O-])SC3CCCCC3.[CA+2].